Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199
2021 · Journal of Translational Medicine · 32 citations
https://doi.org/10.1186/s12967-021-02848-9
X
Xiangjie Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
783
Citations
16
h-index
23
i10-index
Xiangjie Lin is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Cancer, Hypoxia, and Metabolism & Chronic Lymphocytic Leukemia Research. The author has an h-index of 16, co-authored 48 publications.
ORCID: 0000-0003-3549-1359Papers by this author
worksAging and comprehensive molecular profiling in acute myeloid leukemia
2024 · Proceedings of the National Academy of Sciences · 21 citations
https://doi.org/10.1073/pnas.2319366121
Identification of a novel NPM1 mutation in acute myeloid leukemia
2023 · Experimental Hematology and Oncology · 10 citations
https://doi.org/10.1186/s40164-023-00449-4
circSLC25A13 acts as a ceRNA to regulate AML progression via miR‐616‐3p/ADCY2 axis
2023 · Molecular Carcinogenesis · 7 citations
https://doi.org/10.1002/mc.23598
α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment
2025 · Blood Advances · 7 citations
https://doi.org/10.1182/bloodadvances.2024014805
Tryptanthrin impairs platelet function and thrombus formation by reducing Gp1bα expression
2025 · European Journal of Pharmacology · 4 citations
https://doi.org/10.1016/j.ejphar.2025.177332
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat